Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1089 | 1010 | 1243 | 1097 | 1589 | 2513 |
Fund Return | 8.91% | 1.02% | 24.27% | 3.13% | 9.7% | 9.65% |
Place in category | 290 | 239 | 300 | 83 | 211 | 101 |
% in Category | 76 | 65 | 82 | 29 | 66 | 47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dreyfus Strategic Value I | 5.38B | 17.58 | 12.26 | 11.56 | ||
Dreyfus International Stock I | 3.32B | 3.37 | -0.76 | 6.69 | ||
Dreyfus Stock Index Fund Initial Cl | 3.44B | 20.67 | 8.79 | 12.71 | ||
Dreyfus International Stock Y | 2.48B | 3.37 | -0.72 | 6.72 | ||
Dreyfus S&P 500 Index | 2.51B | 20.47 | 8.55 | 12.44 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
American Funds New Perspective A | 61.86B | 14.97 | 1.86 | 11.03 | ||
American Funds New Perspective R6 | 37.82B | 15.27 | 2.19 | 11.38 | ||
Old Westbury Large Cap Strategies | 25.44B | 18.38 | 3.34 | 7.90 | ||
American Funds New Perspective F2 | 19.07B | 15.15 | 2.08 | 11.26 | ||
American Funds New Economy A | 17.53B | 20.68 | 2.32 | 10.92 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 4.13 | 417.00 | +1.00% | |
Taiwan Semiconductor | US8740391003 | 3.92 | 190.08 | -0.61% | |
Novo Nordisk B | DK0062498333 | 3.61 | 750.9 | +4.03% | |
Mastercard | US57636Q1040 | 3.22 | 520.86 | +1.12% | |
Alphabet C | US02079K1079 | 3.14 | 166.57 | -1.58% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review